Paracetamol in Pregnancy: Uncertain Evidence, Certain Consequences.
Tunnicliffe David J, Cumpston Miranda, Kennedy Debra, Danchin Margie, Teixeira-Pinto Armando
What this study means for families
This article examines claims that paracetamol during pregnancy causes autism. The authors found serious problems with the research that made these claims, including poor study methods and misleading conclusions. They explain how unclear scientific findings can be misused to create public confusion about medication safety during pregnancy.
Summary by AutismInsights from published abstract. This is not a substitute for reading the original paper.
Research summary
This article critically examines a systematic review that claimed paracetamol use in pregnancy is linked to autism, which was cited by US President Trump in 2025. The authors identify significant methodological flaws in the original review, including selective reporting, inappropriate analytical frameworks, and reliance solely on observational studies without establishing causation. The article highlights how scientific uncertainty can be misrepresented in public health discussions, leading to confusion about paracetamol safety during pregnancy. This represents a critical analysis of research quality and scientific communication rather than new evidence about paracetamol-autism associations.
Summary by AutismInsights from published abstract. This is not a substitute for reading the original paper.
Key findings
- 1
The systematic review claiming paracetamol-autism links contained methodological flaws and selective reporting
Confidence: The authors provide a detailed critical analysis of the review's limitationsRelevance: Highlights the importance of evaluating research quality before making clinical recommendations - 2
The review used an environmental health framework rather than evidence-based medicine approach
Confidence: This is explicitly stated as a methodological concern by the authorsRelevance: Inappropriate analytical frameworks can lead to misleading conclusions about causation
Summary by AutismInsights from published abstract. This is not a substitute for reading the original paper.
Clinical implications
Clinicians should be aware of how methodologically flawed research can influence public perception of medication safety. The article emphasizes the need for rigorous evaluation of evidence quality before making clinical recommendations about paracetamol use during pregnancy.
Summary by AutismInsights from published abstract. This is not a substitute for reading the original paper.
Limitations
This is a critical commentary rather than original research. The analysis is limited to evaluating an existing systematic review and does not present new empirical data about paracetamol use or autism outcomes.
Summary by AutismInsights from published abstract. This is not a substitute for reading the original paper.
Original abstract
Autism diagnoses have increased over the past decade, prompting debate on potential causes. In September 2025, US President Donald Trump claimed that paracetamol is a 'big factor' in autism, citing a systematic review based solely on observational studies. The review's selective reporting, methodological flaws (including applying an environmental health rather than evidence-based medicine framework) and lack of causal evidence provided weak justifications for its conclusions and have fuelled public confusion about paracetamol safety in pregnancy. This article critically appraises the review and examines how scientific uncertainty can be manipulated and amplified within broader public health domains.
Evidence Grade
limited
Grade assigned by AutismInsights based on study type and published abstract.
Study Details
- Type
- Systematic Review
- Journal
- The Medical journal of Australia
- Year
- 2026
- PMID
- 42135262
- DOI
- 10.5694/mja2.70203
MeSH Terms